Latest News: Proscia Receives FDA 510(k) Clearance For Concentriq AP-DxREAD THE PRESS RELEASE

Proscia’s AI Selected for Skin Pathology

Proscia
By Author Proscia | September 14, 2022

Unilabs has chosen Proscia’s DermAI* to advance its aspiration of becoming the most digitally-driven diagnostic group – enabling better decisions for a healthier tomorrow. The artificial intelligence-enabled technology will first be deployed in Sweden and then rolled out across other countries where Unilabs serves patients.

*DermAI is for research use only.

Our website uses cookies. By using this site, you agree to its use of cookies.